← All articles

Routine3 min read

The dose cycle: why hunger and symptoms change between doses

Between doses, the medication level in your body rises, holds steady and falls. Learn why hunger returns before your next dose and nausea comes right after.

What happens in your body between doses

GLP-1 medications act on appetite, in the brain, and they also slow down how fast your stomach empties: food stays there longer. That’s what helps you feel full, and it’s also where nausea, reflux and that overly full feeling come from.

With a weekly dose, the effect starts climbing in the hours after the dose, stays constant for a few days and gradually eases off until the next one. When the next dose goes in, the previous one hasn’t fully left your body yet, and the cycle starts again. Semaglutide takes about a week to fall to half its level in the body, and tirzepatide about 5 days: that’s why both are injected once a week. What you feel shifts along with that curve, and that’s expected.

The four phases

The days in each phase vary with the interval between doses, with the dose itself and from person to person. The general shape looks like this:

  • Rising: the effect climbs and appetite runs lower. You fill up fast, and mild nausea may show up. Smaller meals and sips of water throughout the day tend to go down better.
  • Steady phase: the effect stays constant, without big swings. Appetite tends to feel similar from one day to the next, and your bowels may slow down; protein and fiber at meals help.
  • Falling: the level starts to drop, hunger slowly comes back and your energy may go up and down.
  • Lowest point: the day before your next dose, with your appetite closer to usual.

Symptoms have their own rhythm too

Stomach and bowel side effects, like nausea, constipation and reflux, are the most common ones on treatment. They tend to cluster at the start and in the days and weeks after each dose increase, and they usually ease over time.

Within the weekly cycle, many people feel more nauseous in the first days after the dose. It’s a common observation in practice, not a rule: your own logs are what tell you whether it applies to you. If it does, keeping those days to lighter meals often helps.

When hunger comes back

Hunger returning in the second half of the cycle worries people who think the medication has stopped working. It’s the phase of the cycle when hunger comes back, not a sign of failure. What tends to keep hunger in check best on those days:

  • Protein and fiber at every meal, which keep you full for longer.
  • Vegetables and soup to add volume to your plate.
  • Smaller portions, more often, always with protein.
  • Regular mealtimes and enough sleep: sleeping too little makes you hungrier.

And if you take a dose every day

With a daily dose, like a liraglutide (Saxenda, Victoza) injection or a semaglutide tablet (Rybelsus), the medication stays at a similar level from one day to the next. There’s no rise on dose day and no dip before the next one, and hunger and nausea, when they show up, don’t follow a set day of the week.

When to get help

Vomiting that won’t stop, severe abdominal pain that doesn’t let up, signs of dehydration, or blood in your vomit or stool are not an expected part of the cycle: get medical care without waiting for your next appointment. Adjusting or delaying a dose because of symptoms is a decision for the person who prescribes it.

In Morphi

We show which day of the cycle you’re on and what usually comes with each phase, and, if you like, a reminder arrives before your next dose. The hunger and symptoms you log appear across the cycle, so you can see how they change.

Sources

Written by the Morphi team from these sources, the same ones Morphi Intelligence uses. It is not a medical review and does not replace advice from your care team.

  1. Prescribing information for GLP-1 medications approved by the FDA, the EMA and ANVISA (pharmacology and adverse reactions).
  2. Wharton S. et al. Postgraduate Medicine, 2022 (recommendations on gastrointestinal effects in obesity treatment).
  3. Mozaffarian D. et al. American Journal of Clinical Nutrition, 2025 (joint advisory on nutrition in GLP-1 treatment from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society).

Morphi doesn’t replace your doctor’s guidance and isn’t for emergencies. Any change to your treatment is a decision for the two of you.

Updated

Download Morphi

Start today, at your own pace

Download now and do your first check-in in under a minute.